Next month, IRB Trade will join Revitacare UK and Laboratoire Revitacare France for the IMCAS World Congress 2022, joining industry professionals from across the UK and around the globe for one of the biggest exhibitions in the industry.
Held at the prestigious Palais De Congress in Paris on June 3 to 5, the highly anticipated IMCAS congress will be the first one back in 2.5 years following the Covid-19 Pandemic and will bring world-renowned experts together for an intensive educational congress that covers major themes across dermatology, plastic surgery, and aging science.
Renowned as a key player in the field of aesthetic medicine for over 20 years, Revitacare provides a range of injectable medical devices based upon hyaluronic acid and specialised ingredients to prevent and correct the visible signs of ageing.
Currently, there are four main products within the range, including the world-renowned Cytocare, which combines Hyaluronic acid and a unique rejuvenating complex to smooth fine lines, firm and smooth the skin, promote elasticity and boost overall radiance within the skin.
The Cytocare line also includes Cytocare 532 and an S-Line variation which are perfect for use around the delicate eye area to brighten, and treat the peri-orbital bone. Cytocare 532 contains 32 mg of non cross linked Hyaluronic acid, and the S – Line variation is a pre-filled syringe containing 18 mg of non cross linked Hyaluronic acid.
The Revitacare range also includes the Haircare line which is ideal for treating a range of concerns, including male pattern baldness. The haircare line combines Hyaluronic acid with Zinc and Biotin to target and strengthen the hair follicle, hydrate the scalp and improve overall hair texture and strength.
Based on its use, each product within the Revitacare line nourishes the deeper layers of skin to provide smooth, natural, and long-lasting results. Based on its intended use, each line is available in a wide range of viscosities and concentrations available and can be used either alone, or in conjunction with other treatments including PRP and Microneedling.
Malieh Hillman, Director of IRB Trade comments: “We are thrilled to be attending the IMCAS event in June. The pandemic has meant this event had to be postponed, so this is the first time in two years we can properly reconnect with Laboratoire Revitacare and many of our colleagues and esteemed practitioners from all over the world.
With the Revitacare range, we are excited to showcase the world-renowned Cytocare range, introduce the latest innovations to new practitioners and be able to demonstrate how each product works both alone and in conjunction with other aesthetic treatments.”
Saleh Roudi, Business Partner at IRB Trade adds: This industry moves on so quickly, but with the pandemic a lot of things were delayed. IMCAS is a great opportunity for us to catch up and learn about the new innovations, trends, and products that will help shape the industry in the future.”
The IMCAS event will be taking place on Friday 3rd, Saturday 4th and Sunday 5th June 2022.